← FDA DRUG APPROVALS

FDA NDA · NDA018605

AZULFIDINE

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
NDA018605
TYPE
NDA
ORIGINAL APPROVAL
1980-12-29
LATEST ACTION
1990-07-18
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

AZULFIDINEDiscontinued
SULFASALAZINE 250MG/5ML · SUSPENSION · ORAL

Approval history

1990-07-18Labeling · Supplement 10AP
1985-02-05Labeling · Supplement 6AP
1983-12-19Labeling · Supplement 9AP
1981-07-21Labeling · Supplement 3AP
1980-12-29Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →